Newport Beach, CA, December 21, 2020 – CureDuchenne, a leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, announced today a new initiative to deliver […]
CURE DUCHENNE VENTURES INVESTMENT SUPPORTS THE DEVELOPMENT OF A NEW THERAPY FOR BONE WASTAGE IN DUCHENNE MUSCULAR DYSTROPHY Newport Beach, CA (November 10, 2020) – CureDuchenne Ventures, the research funding […]
Nonprofit Provided Early-Stage Funding to Accelerate Treatments for Duchenne Muscular Dystrophy Newport Beach, CA (September 25, 2020) – CureDuchenne, a leading global nonprofit dedicated to finding and funding a cure […]
Newport Beach, CA, June 15, 2020 – CureDuchenne, a leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, announced today that Joanna Kemp, BSN, RN, […]
Newport Beach, CA, May 15, 2020 – CureDuchenne, a leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, congratulates Pfizer for announcing data from subjects […]
Newport Beach, CA, May 7, 2020 – CureDuchenne, a leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, is announcing the Virtual Napa Wine Series […]
Newport Beach, CA & Seattle, WA, April 22, 2020: Myosana Therapeutics, Inc., a new biotech company developing novel platform technology for non-viral gene delivery, raised up to $1M in seed […]
WALTHAM, Mass., March 31, 2020 – Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced an equity investment from CureDuchenne Ventures. The funding […]
NEWPORT BEACH, Calif., (March 24, 2020) – CureDuchenne, the leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, is rolling out a comprehensive suite of online resources for […]
